Aerie Pharmaceuticals

Aerie Pharmaceuticals
Last activity: 18.11.2019
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care. Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye. See the future of eye care with Aerie.
Location: United States, North Carolina, Durham
Member count: 501-1000
Total raised: $254M
Founded date: 2005

Investors 3

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
07.03.2011Series B$41M-medcitynew...

Mentions in press and media 6

18.11.2019Aerie Pharmaceuticals announces agreement to acquire Avizore...18/11/2019 Press Release AERIE PHARMACEUTICALS ANNOUNCES AGREEMENT TO ACQUIRE AVIZOREX PHARMA, S.L...webcapital...
01.10.2014 Aerie Pharmaceuticals Completes $125M Financing Newport Beach-based pharmaceuticals developer Aerie Pharmaceuticals said late Tuesday that it has co...socaltech....
09.09.2014 Aerie Pharmaceuticals Raises $125M Newport Beach-based Aerie Pharmaceuticals said today that it has raised $125M in a convertible note ...socaltech....
07.03.2011Aerie Pharmaceuticals Raises $30M in Series B FinancingAerie Pharmaceuticals Inc., a Bridgewater, N.J.-based biotechnology company that develops medical
02.03.2011Glaucoma treatment pharma company Aerie closes $41M venture ...Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficient...medcitynew...
-Glaucoma treatment pharma company Aerie closes $41M venture ...Glaucoma treatment company Aerie Pharmaceuticals has closed a $41.3 million round of financing as th...medcitynew...